Melbourn Herts, United Kingdom

Hugo Revellat


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Hugo Revellat in Injection Device Technology

Introduction

Hugo Revellat is an accomplished inventor based in Melbourn, Herts, GB. He has made significant contributions to the field of medical devices, particularly in the development of injection technology. His innovative approach has led to the creation of a unique injection device that enhances usability and safety.

Latest Patents

Hugo Revellat holds a patent for an injection device that comprises a housing and a cap at the distal end of the housing. The cap includes an outer member and an intermediate member, with at least one of these components being rotatable relative to the other. Additionally, an inner member is disposed within the intermediate member, designed to engage a needle shield in the housing. The device features a lifting mechanism that reduces the force required to remove the cap from the housing, converting rotational movement into axial movement of the inner member.

Career Highlights

Hugo Revellat is currently employed at Sanofi, a global healthcare leader. His work at Sanofi has allowed him to focus on developing innovative solutions that improve patient care and streamline medical procedures. His dedication to advancing medical technology is evident in his patent and ongoing projects.

Collaborations

Hugo has collaborated with notable colleagues, including Uwe Dasbach and Alex Zuyev. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise in the field of medical device innovation.

Conclusion

Hugo Revellat's contributions to injection device technology exemplify his commitment to improving healthcare solutions. His innovative designs and collaborative efforts continue to make a significant impact in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…